HOB Biotech (China) Top Management
688656 Stock | 110.10 0.10 0.09% |
HOB Biotech employs about 550 people. The company is managed by 9 executives with a total tenure of roughly 1284 years, averaging almost 142.0 years of service per executive, having 61.11 employees per reported executive. Analysis of HOB Biotech's management performance can provide insight into the company performance.
John Li Chairman Chairman GM |
HOB |
HOB Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0266 % which means that it generated a profit of $0.0266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0439 %, meaning that it generated $0.0439 on every $100 dollars invested by stockholders. HOB Biotech's management efficiency ratios could be used to measure how well HOB Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, HOB Biotech's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 16.5 M, whereas Total Assets are forecasted to decline to about 526.8 M.As of December 12, 2024, Common Stock Shares Outstanding is expected to decline to about 57.6 M
HOB Biotech Workforce Comparison
HOB Biotech Group is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2.75 Million. HOB Biotech adds roughly 550 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07. HOB Biotech Group Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. HOB Biotech Group Price Series Summation is a cross summation of HOB Biotech price series and its benchmark/peer.
HOB Biotech Notable Stakeholders
A HOB Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as HOB Biotech often face trade-offs trying to please all of them. HOB Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting HOB Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Li | Chairman GM | Profile | |
Qingxin Liu | Director GM | Profile | |
Xiaohua Huang | Deputy Manager | Profile | |
Ruoliang Sun | Deputy Manager | Profile | |
Shuyan Han | Chief Officer | Profile | |
Aixiang Xie | Secretary | Profile | |
Yi Li | Financial Manager | Profile | |
Kai Wang | Board GM | Profile | |
Jerry Li | Chief Officer | Profile |
About HOB Biotech Management Performance
The success or failure of an entity such as HOB Biotech Group often depends on how effective the management is. HOB Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of HOB management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the HOB management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
HOB Biotech is entity of China. It is traded as Stock on SHG exchange.
Please note, the presentation of HOB Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HOB Biotech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of HOB Biotech's management manipulating its earnings.
HOB Biotech Workforce Analysis
Traditionally, organizations such as HOB Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare HOB Biotech within its industry.HOB Biotech Manpower Efficiency
Return on HOB Biotech Manpower
Revenue Per Employee | 717.1K | |
Revenue Per Executive | 43.8M | |
Net Income Per Employee | 87.1K | |
Net Income Per Executive | 5.3M | |
Working Capital Per Employee | 349.9K | |
Working Capital Per Executive | 21.4M |
Complementary Tools for HOB Stock analysis
When running HOB Biotech's price analysis, check to measure HOB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HOB Biotech is operating at the current time. Most of HOB Biotech's value examination focuses on studying past and present price action to predict the probability of HOB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HOB Biotech's price. Additionally, you may evaluate how the addition of HOB Biotech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |